{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:12Z","timestamp":1787024532978,"version":"build-2736575974"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.2169\/internalmedicine.2321-18","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:06:53Z","timestamp":1553710013000},"page":"1865-1870","source":"Crossref","is-referenced-by-count":15,"title":["Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib"],"prefix":"10.2169","volume":"58","author":[{"given":"Akihito","family":"Fujimi","sequence":"first","affiliation":[{"name":"Department of Hematology, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nagamachi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Nishisato","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sapporo Kiyota Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichi","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol 151: 33-40, 2000.","DOI":"10.1093\/oxfordjournals.aje.a010118"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 17: 562-570, 2002.","DOI":"10.1177\/088307380201700804"},{"key":"3","unstructured":"3. Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol 18: 475-484, 2005."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 22: 3813-3825, 2004.","DOI":"10.1200\/JCO.2004.05.140"},{"key":"5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"5. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577-580, 1998.","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer 19: 3-14, 2016.","DOI":"10.1007\/s10120-015-0526-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 15: 1015-1023, 2006.","DOI":"10.1093\/hmg\/ddl016"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Segawa K, Sugita S, Sugawara T, et al. Multiple gastrointestinal stromal tumors involving extragastrointestinal sites in neurofibromatosis type 1. Pathol Int 68: 142-144, 2018.","DOI":"10.1111\/pin.12620"},{"key":"9","unstructured":"9. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [<sup>18<\/sup>F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35: 1773-1782, 1999."},{"key":"10","unstructured":"10. Huss S, Elges S, Trautmann M, Sperveslage J, Hartmann W, Wardelmann E. Classification of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy. Expert Rev Anticancer Ther 15: 623-628, 2015."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Corless CL. Gastrointestinal stromal tumors: what do we know now? Mod Pathol 27: S1-S16, 2014.","DOI":"10.1038\/modpathol.2013.173"},{"key":"12","unstructured":"12. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 30: 90-96, 2006."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. The ESMO\/European Sarcoma Network Working Group. Ann Oncol 25 (Supple): iii21, 2014.","DOI":"10.1093\/annonc\/mdu255"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Etit D, Kar H, Ekinci N, Yenipazar AE, \u00c7akala\u011fao\u011flu F. Extra-gastrointestinal stromal tumor of prostate. Balkan Med J 34: 168-171, 2017.","DOI":"10.4274\/balkanmedj.2015.1331"},{"key":"15","unstructured":"15. Malhotra A, Wright J, Gajra A. Extra gastrointestinal stromal tumor treated with imatinib in a patient with neurofibromatosis type 1. J Gastrointest Oncol 3: 373-376, 2012."},{"key":"16","unstructured":"16. Casali PG, Zalcberg J, Le Cesne A, et al. Ten-year progression-free and overall survival in patients with unresectable or metastatic GI stromal tumors: long-term analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III randomized trial on imatinib at two dose levels. J Clin Oncol 35: 1713-1720, 2017."},{"key":"17","unstructured":"17. Wilhelm SM, Dumas J, Adnane L, et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer 129: 245-255, 2011."},{"key":"18","unstructured":"18. Mendel DB, Laird AD, Xin X, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship. Clin Cancer Res 9: 327-337, 2003."},{"key":"19","unstructured":"19. Kalender M, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report. World J Gastroenterol 13: 2629-2632, 2007."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2321-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T23:43:18Z","timestamp":1562370198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2321-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":19,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2321-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}